☆ 4.6 Letter

Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction

CIRCULATION-HEART FAILURE (2022)

Get Full Text
Add to Collection

Journal

CIRCULATION-HEART FAILURE
Volume 15, Issue 10, Pages -

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCHEARTFAILURE.121.009295

Keywords

eplerenone; morbidity; myocardial infarction; prognosis; spironolactone

Categories

Cardiac & Cardiovascular Systems

Funding

  1. McGill Lucien Award
  2. Canada Institute for Health Research [175095]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.